BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2023 8:16:12 AM | Browse: 392 | Download: 1303
 |
Received |
|
2022-12-15 00:54 |
|
Peer-Review Started |
|
2022-12-15 00:57 |
|
First Decision by Editorial Office Director |
|
2023-01-18 22:15 |
|
Return for Revision |
|
2023-01-18 22:15 |
|
Revised |
|
2023-01-19 12:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-03-15 03:08 |
|
Second Decision by Editor-in-Chief |
|
2023-03-16 00:46 |
|
Final Decision by Editorial Office Director |
|
2023-03-21 19:09 |
|
Articles in Press |
|
2023-03-21 19:09 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-04-18 04:19 |
|
Publish the Manuscript Online |
|
2023-04-26 08:16 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tang-Her Jaing, Tsung-Yen Chang and Chia-Chi Chiu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tang-Her Jaing, MD, Chief Physician, Director, Director, Professor, Division of Hematology, Oncology, Department of Pediatrics, Chang Gung Children’s Hospital, Chang Gung University, No. 5 Fu-Shin Street, Kwei-Shan, Taoyuan 333, Taiwan. jaing001@cgmh.org.tw |
| Key Words |
Mesenchymal stem/stromal cells; Graft-versus-host disease; Immunomodulatory; Adaptive immunity; Exosomes |
| Core Tip |
This article provides insights into the use of validated mesenchymal stem/stromal cells (MSCs) as a potential treatment strategy for graft-versus-host disease (GVHD) in hematopoietic stem cell transplantation (HSCT). Current prevention and treatment options involve immunosuppression, which can hinder immune recovery and limit the graft-versus-tumor effect. By using MSCs, clinicians can effectively treat GVHD, identify high-risk patients, and stratify patients based on disease severity. Therefore, MSCs can aid in promoting engraftment, ameliorating acute GVHD, and preventing chronic GVHD, making them an attractive option for HSCT. |
| Publish Date |
2023-04-26 08:16 |
| Citation |
Jaing TH, Chang TY, Chiu CC. Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease. World J Stem Cells 2023; 15(4): 221-234 |
| URL |
https://www.wjgnet.com/1948-0210/full/v15/i4/221.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v15.i4.221 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
